Clinical Trial Data
The latest news about Clinical Trial Data: headlines, AI summaries and the full story from every source.
- Novartis Reports Long-Term Efficacy for Ianalumab in Sjögren’s Disease Patients
- Upstream Bio Reports Third Quarter Financial Results
- PepGen Shares Surge Following Positive Mid-Stage Trial Data for Myotonic Dystrophy Therapy
- AbCellera Reports Q3 2026 Results and Positive Phase II Data for ABCL635
- Structure Therapeutics Reports Q3 Financial Results and Clinical Updates
- Coherus BioSciences Reports Q3 Non-GAAP EPS Beat Amid Revenue Miss
- OrthoTrophix Reports Data Suggesting TPX-100 May Slow Knee Osteoarthritis Progression
- AC Immune Reports Q3 Revenue Growth of 244.7% Amid Continued Pipeline Expansion
- Regeneron Reports 36% Year-Over-Year Revenue Growth in Q3 2026
- Iovance Biotherapeutics Shares Drop 34% Following Phase 2 Amtagvi Data for Lung Cancer
- CREATE Medicines to Present In Vivo CAR-T Preclinical Data at APLAR 2026 Congress
- Xencor Shares Rise 16% Following Positive Early Clinical Data for XmAb819
- Arcus Biosciences Shares Drop 20% Following Stock Offering and Kidney Cancer Clinical Data
- Biogen's Litifilimab Shows Positive Long-Term Results in Cutaneous Lupus Trial
- Investor Alert: Pomerantz Law Firm Investigates Potential Securities Fraud at Beam Therapeutics
- Lawsuit Filed Against Capricor Therapeutics Over Alleged Securities Violations
- Allogene Reports Q2 2026 Financials and Clinical Trial Updates
- Pomerantz Law Firm Announces Class Action Lawsuit Against Erasca, Inc.
- Pomerantz Law Firm Investigates Larimar Therapeutics Over Alleged Securities Fraud
- Class Action Lawsuit Filed Against Erasca, Inc.